Related Experiment Videos
Safety considerations in treating concomitant diseases in patients with asthma
1Mayo Clinic and Graduate School of Medicine, Rochester, Minnesota, USA.
Drug Safety
|May 20, 1998
Summary
Managing asthma in older adults requires careful attention due to complex medication regimens. Co-existing conditions and their treatments can interfere with asthma control, necessitating vigilant supervision.
Area of Science:
- Pulmonology
- Geriatrics
- Clinical Pharmacy
Background:
- Asthma management typically involves bronchodilators and anti-inflammatory drugs.
- Severe asthma often requires complex polypharmacy.
- Aging populations present unique challenges in medication management due to comorbidities.
Purpose of the Study:
- To highlight the complexities of managing asthma in elderly patients with multiple comorbidities.
- To identify potential drug interactions between asthma medications and treatments for common age-related diseases.
- To emphasize the need for comprehensive medication review in this patient population.
Main Methods:
- Review of common age-related diseases and their typical pharmacotherapies.
- Analysis of potential drug-drug interactions impacting asthma control.
- Discussion of clinical strategies for managing polypharmacy in elderly asthmatics.
Main Results:
- Common comorbidities like joint, eye, cardiovascular, neurological, and urological diseases necessitate medications that can interfere with asthma.
- Nonsteroidal anti-inflammatory agents can provoke wheezing in intrinsic asthma.
- Beta-blockers, used for eye and cardiovascular conditions, can exacerbate asthma.
Conclusions:
- Managing elderly asthma patients with comorbidities requires meticulous supervision of all medications.
- Regular and thorough review of the entire medication list at each clinical encounter is crucial.
- Proactive identification and management of drug interactions are essential for optimal asthma control and patient safety.